Suppr超能文献

Loop 利尿剂的独特作用机制。

Loop Diuretics Unique Mechanism of Action.

机构信息

Senior Consultant Interventional Cardiologist, Department of Cardiology, Cardiac Consultant Hospital, Rajkot, Gujarat, India, Corresponding Author.

Consultant Interventional Cardiologist, Department of Cardiology, SMS Hospital, Jaipur, Rajasthan, India.

出版信息

J Assoc Physicians India. 2024 Sep;72(9S):14-15. doi: 10.59556/japi.72.0670.

Abstract

Loop diuretics, including torsemide, furosemide, bumetanide, and piretanide, act by inhibiting the sodium-potassium-chloride (Na/K/2Cl) cotransporter in the thick ascending limb of the loop of Henle within the nephron. This mechanism is pivotal in managing fluid retention associated with conditions such as heart failure, cirrhosis, chronic kidney disease, and hypertension. A comprehensive understanding of how these diuretics uniquely target this transporter provides crucial insights into effectively addressing fluid overload across diverse clinical conditions.

摘要

袢利尿剂,包括托塞米、呋塞米、布美他尼和吡嗪酰胺,通过抑制肾单位中的亨利袢升支粗段中的钠-钾-氯(Na/K/2Cl)共转运体来发挥作用。这种机制对于管理与心力衰竭、肝硬化、慢性肾脏病和高血压等疾病相关的液体潴留至关重要。全面了解这些利尿剂如何独特地靶向该转运体,为在各种临床情况下有效解决液体超负荷提供了重要的见解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验